Skip to main content
Caplight Logo









CarrTech

CarrTech

Private
Frederick, MarylandHealthcare & Life Scienceshttps://carrtechcorp.com

Last Round

Seed

May 25, 2023

Total Funding Raised

$1.35M

Company Overview

CarrTech operates in Healthcare & Life Sciences and is based in Frederick, Maryland. Its latest recorded funding round was a Seed round in May 2023.

CarrTech is a medical device company that develops innovative medication preparation solutions, including its flagship FROG (Filter Removal of Glass) needle technology designed to improve safety and efficiency in clinical settings.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CarrTech Comparables

Compare CarrTech with similar companies based on industry and business-model similarity.

CarrTech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sol-Millennium Medical
78%
Terumo Corporation
76%
ICU Medical Inc
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CarrTech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMay 25, 2023
SeedNov 17, 2021
Pre SeedJul 6, 2020
GrantJun 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CarrTech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors grew 42% MoM, reaching 1.2K.

  • May 25, 2023

    $750K raised from Old Line Capital Partners and TEDCO.

Book a demo to see all signals

For institutional investors. Book with your work email.

CarrTech Filings

Explore SEC and related filing metadata, where available.

CarrTech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CarrTech's valuation, stock price, and market status.

Is CarrTech a public or private company?

CarrTech is a private company.

What is the current stock price of CarrTech?

CarrTech is a private company, so its shares have no public market price. Caplight tracks CarrTech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CarrTech worth (valuation)?

Valuation information for CarrTech is not publicly available.

Can I buy CarrTech stock?

CarrTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CarrTech's last funding round?

CarrTech's most recent funding round was Seed on May 25, 2023.

Who are the main investors in CarrTech?

Key investors in CarrTech include Old Line Capital Partners.

Will CarrTech IPO soon?

No public IPO plans have been announced for CarrTech.

How can I track CarrTech secondary market activity?

Caplight tracks bids, offers, and trades in CarrTech's shares on secondary markets.

Firmographic Details

HeadquartersFrederick, Maryland
Employee Range3
Year FoundedN/A
Last FundingMay 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?